![Levothyroxine Sodium Capsules](/cache/it_mahal/05660b68809c24f1484fe8e8e2840bce.jpeg)
![Are we prescribing antibiotics wrong?](https://www.pharmatechglobal.net/images/articles/imgs/antibiotics_article2018.jpg)
Are we prescribing antibiotics wrong?
![Outsourcing Clinical Trials Outside of the US](https://www.pharmatechglobal.net/images/articles/imgs/outsourcing_ct_outsideus.jpg)
Outsourcing Clinical Trials Outside of the US
![Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma](https://www.pharmatechglobal.net/images/articles/imgs/dna_pharma2018.jpg)
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
![Two-dimensional liquid chromatography with multiple heart-cutting](https://www.pharmatechglobal.net/images/articles/imgs/Article_Main1.jpg)
Two-dimensional liquid chromatography with multiple heart-cutting
![Understanding Pharmaceutical Logistics Validation in a Dynamic Environment](https://www.pharmatechglobal.net/images/articles/imgs/uplv2018.jpg)
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment
![Are we prescribing antibiotics wrong?](https://www.pharmatechglobal.net/images/articles/imgs/antibiotics_article2018.jpg)
![Outsourcing Clinical Trials Outside of the US](https://www.pharmatechglobal.net/images/articles/imgs/outsourcing_ct_outsideus.jpg)
![Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma](https://www.pharmatechglobal.net/images/articles/imgs/dna_pharma2018.jpg)
![Two-dimensional liquid chromatography with multiple heart-cutting](https://www.pharmatechglobal.net/images/articles/imgs/Article_Main1.jpg)
![Understanding Pharmaceutical Logistics Validation in a Dynamic Environment](https://www.pharmatechglobal.net/images/articles/imgs/uplv2018.jpg)
Latest White Papers
- Random
Featured News
Latest News
- Title
- Most Views
- Recently Added
- Ordering
- Random
![Load More](https://www.pharmatechglobal.net//modules/mod_sj_content_super_category/assets/images/add.png)
![Load More](https://www.pharmatechglobal.net//modules/mod_sj_content_super_category/assets/images/add.png)
![BioRise in chamber version 1 BioRise in chamber version 1](/cache/resized/4c9bd7946c8b74d030243868eeea4164.jpg)
Akadeum Life Sciences is excited to announce its participation Mesa, a globally recognized program ...
![New, pilot-scale 65-liter high shear granulator New, pilot-scale 65-liter high shear granulator](/cache/resized/5466c1138a06a415717b5bc391e0b80c.jpg)
To provide flexible and innovative solutions for early development challenges commonly faced by ...
![Needlestick Needlestick](/cache/resized/8479a3cc8e00e874b3b26a5d95cde678.jpg)
With a surge in needlestick injuries becoming a pressing issue, BioMedical Waste Solutions, a top ...
![Bloomage's Bloomage's](/cache/resized/f807f47a6a110a6b562669c2ac38eed4.jpg)
Bloomage released its mid-year financial report, reporting a revenue of RMB 2.811 billion (~USD 385 ...
![Load More](https://www.pharmatechglobal.net//modules/mod_sj_content_super_category/assets/images/add.png)
![Load More](https://www.pharmatechglobal.net//modules/mod_sj_content_super_category/assets/images/add.png)
![Load More](https://www.pharmatechglobal.net//modules/mod_sj_content_super_category/assets/images/add.png)
Latest Updates
BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to ...
BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs.
The BioButton Multi-Patient medical device ...
PeptiGrowth Inc.has successfully developed a novel synthetic peptide called "FGF2 alternative peptide (FGFR1c agonist)", which has equivalent function to recombinant FGF2 (Fibroblast Growth Factor 2, ...
PeptiGrowth Inc.has successfully developed a novel synthetic peptide called "FGF2 alternative peptide (FGFR1c agonist)", which has equivalent function to recombinant FGF2 (Fibroblast Growth Factor 2, basic FGF (bFGF)). This product will be on the market at the beginning of October 2024.
...
Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance biological ...
Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance biological modeling. Constructed using low-drug-absorbing plastics, Chip-R1 builds upon the core microfluidic ...
Spineology Inc., the pioneer of Conform and Expand™ Technology, unveiled a new brand and visual identity, logo, and product positioning as part of an extensive rebranding initiative. This new brand ...
Spineology Inc., the pioneer of Conform and Expand™ Technology, unveiled a new brand and visual identity, logo, and product positioning as part of an extensive rebranding initiative. This new brand defines Spineology’s flagship interbody fusion portfolio, OptiMesh®, and establishes it within a ...
Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced an expansion in capabilities through the licensing of ATUM's innovative miFuc™ platform designed for ...
Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced an expansion in capabilities through the licensing of ATUM's innovative miFuc™ platform designed for expression of recombinant proteins containing afucosylated glycans.
ATUM's miFuc™ technology is ...
Axion BioSystems and STEMCELL Technologies are pleased to announce a strategic partnership that will enable STEMCELL to sell Axion’s state-of-the-art Maestro Pro™ and Maestro Edge™ multielectrode ...
Axion BioSystems and STEMCELL Technologies are pleased to announce a strategic partnership that will enable STEMCELL to sell Axion’s state-of-the-art Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems within North America and Europe. The industry-leading Maestro MEA systems will also ...